Devyser Diagnostics AB (publ) (DVYSR.ST) — Stock Score Summary

Devyser Diagnostics AB (publ) (DVYSR.ST) has a MoatMap StockRank of 18/100 based on Quality (58/100), Value (21/100), and Momentum (25/100) factor scores. The current signal is STRONG SELL. Niche diagnostics company with high growth but lacking the scale, pricing power, and established moat of a true quality compounder.

Devyser Diagnostics AB is a Swedish medical technology company that develops, manufactures, and sells easy-to-use diagnostic kits for complex DNA testing within oncology, transplantation, and hereditary diseases. The company's proprietary Next-Generation Sequencing (NGS) workflows significantly reduce laboratory processing times from days to hours. Devyser's highly scalable, high-margin business model is supported by a growing global distribution network and direct sales in key European and US markets.

Key Financial Metrics

Price$9.92
Market Cap$166M
P/E (TTM)105.11
P/E (Forward)155.08
Price/Book4.40
Return on Equity4.4%
Return on Invested Capital0.1%
Debt/Equity13.69
Gross Margin80.3%
Operating Margin4.5%
Revenue Growth12.8%
Free Cash Flow$-412K

Devyser Diagnostics AB (publ) operates in the Medical Devices industry, part of the Healthcare sector (Sweden).

Frequently Asked Questions

What is Devyser Diagnostics AB (publ)’s (DVYSR.ST) StockRank?
MoatMap’s StockRank for Devyser Diagnostics AB (publ) (DVYSR.ST) is 18/100, with a Strong Sell signal. It is a composite of Quality (58), Value (21), and Momentum (25) factor ranks across MoatMap’s 19,000+ stock universe.
Does Devyser Diagnostics AB (publ) have an economic moat?
Devyser Diagnostics AB (publ) (DVYSR.ST) has a Quality factor score of 58/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Devyser Diagnostics AB (publ) a buy, hold, or sell?
MoatMap’s current signal for Devyser Diagnostics AB (publ) (DVYSR.ST) is Strong Sell, based on a StockRank of 18/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Devyser Diagnostics AB (publ) in?
Devyser Diagnostics AB (publ) (DVYSR.ST) operates in the Healthcare sector, specifically the Medical Devices industry (Sweden).
Browse all ranked stocksDVYSR.ST deep dive reportAI ChampionsHow we score stocksSense-check another stock